ARX Insider Trading

Insider Ownership Percentage: 26.99%
Insider Buying (Last 12 Months): A$224,950.00
Insider Selling (Last 12 Months): A$0.00

Aroa Biosurgery Insider Trading History Chart

This chart shows the insider buying and selling history at Aroa Biosurgery by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Aroa Biosurgery Share Price & Price History

Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 06/28/2019 01:00 AM ET

This chart shows the closing price history over time for ARX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table

Aroa Biosurgery Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/27/2024Steven (Steve) EngleInsiderIssued633,225A$0.10A$62,056.05
2/16/2024Philip McCawInsiderBuy326,000A$0.58A$187,450.00
9/6/2023James (Jim) McLeanInsiderBuy50,000A$0.75A$37,500.00
8/11/2023Catherine MohrInsiderIssued210,686A$0.88A$185,403.68
3/31/2023Philip McCawInsiderIssued172,620A$1.05A$181,251.00
12/14/2022John DiddamsInsiderExercise165,000A$0.11A$17,655.00
4/12/2022Philip McCawInsiderExercise81,925A$0.75A$61,443.75
3/25/2022John DiddamsInsiderBuy165,000A$0.11A$17,655.00
8/19/2021James (Jim) McLeanInsiderExercise102,400A$0.75A$76,800.00
8/6/2021Philip McCawInsiderTransfer2,864,879A$1.15A$3,297,475.73
6/11/2021Philip McCawInsiderBuy81,925A$0.75A$61,443.75
See Full Table

SEC Filings (Institutional Ownership Changes) for Aroa Biosurgery (ASX:ARX)

13.33% of Aroa Biosurgery stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Aroa Biosurgery Limited, a regenerative medicine company, engages in the developing, manufacturing, and sells medical devices for wound and tissue repair using extracellular matrix (ECM) technology in the United States and internationally. Its products include Endoform Natural and Endoform Antimicrobia Restorative Bioscaffold for treating acute and chronic wounds; Myriad Matrix, an engineered ECM for soft tissue repair, reinforcement, and complex wounds; Myriad Morcells, a morcellized (powdered) format of Myriad Matrix for soft tissue repair and complex wounds; and Reinforced Bioscaffolds, a surgical product for use in ventral hernia repair and abdominal wall reconstruction. The company was incorporated in 2007 and is headquartered in Auckland, New Zealand.
Read More on Aroa Biosurgery

Today's Range

Now: N/A

50 Day Range


52 Week Range

Now: N/A



Average Volume


Market Capitalization


P/E Ratio


Dividend Yield




Who are the company insiders with the largest holdings of Aroa Biosurgery?

Aroa Biosurgery's top insider shareholders include:
  1. Catherine Mohr (Insider)
  2. James (Jim) McLean (Insider)
  3. John Diddams (Insider)
  4. Philip McCaw (Insider)
  5. Steven (Steve) Engle (Insider)
Learn More about top insider investors at Aroa Biosurgery.